BR112023018095A2 - Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo - Google Patents
Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmoInfo
- Publication number
- BR112023018095A2 BR112023018095A2 BR112023018095A BR112023018095A BR112023018095A2 BR 112023018095 A2 BR112023018095 A2 BR 112023018095A2 BR 112023018095 A BR112023018095 A BR 112023018095A BR 112023018095 A BR112023018095 A BR 112023018095A BR 112023018095 A2 BR112023018095 A2 BR 112023018095A2
- Authority
- BR
- Brazil
- Prior art keywords
- fluoro
- hydrate
- salt
- nitrotoluene
- bromomethyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- RFUBTTPMWSKEIW-UHFFFAOYSA-N omecamtiv mecarbil Chemical compound C1CN(C(=O)OC)CCN1CC1=CC=CC(NC(=O)NC=2C=NC(C)=CC=2)=C1F RFUBTTPMWSKEIW-UHFFFAOYSA-N 0.000 title abstract 3
- 229950001617 omecamtiv mecarbil Drugs 0.000 title abstract 3
- MIESICVJNXXYKC-UHFFFAOYSA-N 1-(bromomethyl)-2-fluoro-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(CBr)=C1F MIESICVJNXXYKC-UHFFFAOYSA-N 0.000 title abstract 2
- NBCNUIXYBLFJMI-UHFFFAOYSA-N 2-fluoro-1-methyl-3-nitrobenzene Chemical compound CC1=CC=CC([N+]([O-])=O)=C1F NBCNUIXYBLFJMI-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/10—Preparation of nitro compounds by substitution of functional groups by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Abstract
processos para sintetizar 2-fluoro-3-nitrotolueno, 1- (bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo. trata-se de métodos sintéticos para a preparação de intermediários que são utilizados na síntese de dicloridrato de omecamtiv mecarbil.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159227P | 2021-03-10 | 2021-03-10 | |
| PCT/US2022/019573 WO2022192414A2 (en) | 2021-03-10 | 2022-03-09 | Synthesis of omecamtiv mecarbil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023018095A2 true BR112023018095A2 (pt) | 2023-12-12 |
Family
ID=80937110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023018095A BR112023018095A2 (pt) | 2021-03-10 | 2022-03-09 | Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11702380B2 (pt) |
| EP (1) | EP4305018A2 (pt) |
| JP (1) | JP2024509797A (pt) |
| KR (1) | KR20240006498A (pt) |
| CN (1) | CN117157274A (pt) |
| AU (1) | AU2022232919A1 (pt) |
| BR (1) | BR112023018095A2 (pt) |
| CA (1) | CA3212491A1 (pt) |
| CL (1) | CL2023002667A1 (pt) |
| IL (1) | IL305751A (pt) |
| MX (1) | MX2023010558A (pt) |
| TW (1) | TW202300479A (pt) |
| WO (1) | WO2022192414A2 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785265A (zh) | 2013-03-14 | 2018-11-13 | 美国安进公司 | 杂环化合物和其用途 |
| MA49508A (fr) | 2017-06-30 | 2020-05-06 | Amgen Inc | Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaques |
| BR112019028205A2 (pt) | 2017-06-30 | 2020-10-06 | Amgen Inc. | síntese de omecamtiv mecarbil |
| MX2021001792A (es) | 2018-08-17 | 2021-05-27 | Amgen Inc | Sales y formas cristalinas de omecamtiv mecarbil. |
| AU2022232919A1 (en) | 2021-03-10 | 2023-10-19 | Amgen Inc. | Synthesis of omecamtiv mecarbil |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI359812B (en) | 2004-06-17 | 2012-03-11 | Cytokinetics Inc | Compounds, compositions and methods |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| CN101177400A (zh) | 2006-11-06 | 2008-05-14 | 吕铁环 | 一种生产2-氟-3-硝基甲苯的方法 |
| WO2014152198A1 (en) | 2013-03-14 | 2014-09-25 | Amgen Inc. | Heterocyclic compounds and their uses |
| CN108785265A (zh) | 2013-03-14 | 2018-11-13 | 美国安进公司 | 杂环化合物和其用途 |
| AU2016282985B2 (en) | 2015-06-26 | 2021-07-29 | Amgen Inc. | Combination therapy of cardiac myosin activator and sinus node if current inhibitor |
| BR112019028205A2 (pt) | 2017-06-30 | 2020-10-06 | Amgen Inc. | síntese de omecamtiv mecarbil |
| MA49508A (fr) | 2017-06-30 | 2020-05-06 | Amgen Inc | Procédés de traitement d'une insuffisance cardiaque avec des activateurs de sarcomères cardiaques |
| LT3594199T (lt) | 2018-07-09 | 2020-11-10 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Kristalinis 2-fluor-3-nitroluenas ir jo paruošimo būdas |
| US11608318B2 (en) | 2018-07-12 | 2023-03-21 | Assia Chemical Industries Ltd. | Solid state forms of Omecamtiv mecarbil and Omecamtiv mecarbil diHCl |
| MX2021001792A (es) | 2018-08-17 | 2021-05-27 | Amgen Inc | Sales y formas cristalinas de omecamtiv mecarbil. |
| WO2020131574A1 (en) | 2018-12-18 | 2020-06-25 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| WO2021053175A1 (en) | 2019-09-19 | 2021-03-25 | Synthon B.V. | Salts of omecamtiv mecarbil and solid forms thereof |
| WO2021053189A1 (en) | 2019-09-19 | 2021-03-25 | Synthon B.V. | Salts of omecamtiv mecarbil and solid forms thereof |
| WO2021070123A1 (en) | 2019-10-09 | 2021-04-15 | Dr. Reddy’S Laboratories Limited | Solid forms of omecamtiv mecarbil dihydrochloride and processes thereof |
| US20220411374A1 (en) | 2019-10-09 | 2022-12-29 | Dr. Reddy's Laboratories Limited | Alternate processes for the preparation of omecamtiv mecarbil |
| WO2021136477A1 (zh) | 2020-01-03 | 2021-07-08 | 苏州科睿思制药有限公司 | 化合物i二盐酸盐的共晶及其制备方法和用途 |
| CA3168513A1 (en) | 2020-02-10 | 2021-08-19 | Amgen Inc. | Omecamtiv mecarbil tablet |
| MX2023005455A (es) | 2020-11-12 | 2023-07-27 | Amgen Inc | Metodos de tratamiento de la insuficiencia cardiaca mediante la administracion de omecamtiv mecarbil. |
| AU2022232919A1 (en) | 2021-03-10 | 2023-10-19 | Amgen Inc. | Synthesis of omecamtiv mecarbil |
-
2022
- 2022-03-09 AU AU2022232919A patent/AU2022232919A1/en active Pending
- 2022-03-09 MX MX2023010558A patent/MX2023010558A/es unknown
- 2022-03-09 EP EP22712763.6A patent/EP4305018A2/en active Pending
- 2022-03-09 KR KR1020237033048A patent/KR20240006498A/ko unknown
- 2022-03-09 CA CA3212491A patent/CA3212491A1/en active Pending
- 2022-03-09 WO PCT/US2022/019573 patent/WO2022192414A2/en active Application Filing
- 2022-03-09 CN CN202280017907.1A patent/CN117157274A/zh active Pending
- 2022-03-09 IL IL305751A patent/IL305751A/en unknown
- 2022-03-09 TW TW111108611A patent/TW202300479A/zh unknown
- 2022-03-09 JP JP2023552300A patent/JP2024509797A/ja active Pending
- 2022-03-09 BR BR112023018095A patent/BR112023018095A2/pt unknown
- 2022-03-09 US US17/690,729 patent/US11702380B2/en active Active
-
2023
- 2023-09-07 CL CL2023002667A patent/CL2023002667A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11702380B2 (en) | 2023-07-18 |
| KR20240006498A (ko) | 2024-01-15 |
| IL305751A (en) | 2023-11-01 |
| WO2022192414A3 (en) | 2022-10-27 |
| CN117157274A (zh) | 2023-12-01 |
| US20220298099A1 (en) | 2022-09-22 |
| JP2024509797A (ja) | 2024-03-05 |
| MX2023010558A (es) | 2023-11-24 |
| EP4305018A2 (en) | 2024-01-17 |
| AU2022232919A1 (en) | 2023-10-19 |
| TW202300479A (zh) | 2023-01-01 |
| CA3212491A1 (en) | 2022-09-15 |
| WO2022192414A2 (en) | 2022-09-15 |
| CL2023002667A1 (es) | 2024-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023018095A2 (pt) | Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo | |
| CY1122325T1 (el) | Ενωσεις ρυθμισης fxr (nr1h4) | |
| BR112017006253A2 (pt) | novos compostos | |
| TN2018000276A1 (en) | Inhibitors of receptor-interacting protein kinase 1. | |
| CR20190124A (es) | Inhibidores de ssao de aminopirimidina | |
| BR112017024917A2 (pt) | síntese de compostos heterocíclicos | |
| EA202193015A1 (ru) | Ингибиторы cdk | |
| BR112019005129A2 (pt) | anticorpos anti-pd-1 | |
| BR112022000848A2 (pt) | Processo para reduzir a emissão de aldeído, sistema de poliuretano, processo de produção e uso do dito sistema | |
| ECSP23019419A (es) | Proceso e intermedios para preparar un inhibidor de jak1 | |
| UY38233A (es) | Agentes inhibidores para la tirosina cinasa de bruton | |
| MX2018013232A (es) | Sintesis de indazoles. | |
| CO2020000371A2 (es) | Intermedios útiles para la síntesis de un inhibidor selectivo contra proteín cinasas y procesos para preparar los mismos | |
| EA202190756A1 (ru) | Способ использования алканоламина при размоле | |
| MX2017009038A (es) | Antagonistas de proteina 1 de interacción con el receptor de nogo que contiene el dominio de inmunoglobulina y repeticiones ricas en leucina (lingo-1) y usos para el tratamiento de trastornos desmielinizantes. | |
| BR112017004134A2 (pt) | ?sondas para imageamento de proteína de huntingtina? | |
| CY1122728T1 (el) | Αντισωματα εναντι hpa-1a | |
| BR112022008061A2 (pt) | Processo eficaz para síntese de 2-amino-5-cloro-n,3-dimetilbenzamida | |
| CO2022007926A2 (es) | Banco celular maestro de células t | |
| ECSP23019417A (es) | Proceso e intermediarios para preparar un inhibidor de jak | |
| BR112017009854A2 (pt) | composto, uso de um composto, e, método para tratamento de leucemia. | |
| BR112018012325A2 (pt) | métodos para a preparação de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina substituída | |
| AR102088A1 (es) | Procesos para preparar compuestos de (ciclopentil[d]pirimidin-4-il)piperazina | |
| EA201892370A1 (ru) | Замещенные конденсированные пиримидиноновые соединения | |
| CO2020000595A2 (es) | Intermedios novedosos útiles para la síntesis de derivados de aminopirimidina, proceso para prepararlos, y proceso para preparar derivados de aminopirimidina usando estos |